Abstract
Construction of the gene regulatory networks is a challenged problem in systems biology and bioinformatics. This paper presents construction of gene network using combined quantum-behaved PSO and K2 algorithm. Recent studies have shown that Bayesian Network is an effective way to learn the network structure. K2 algorithm is widely used because of its heuristic searching techniques and fast convergence, but it suffers from local optima. And the performance of K2 algorithm is greatly affected by a prior ordering of input nodes. Quantum-behaved PSO is a population-based stochastic search process, which automatically searches for the optimal solution in the search space. So, we combined it with K2 algorithm for construction gene network. The results of hybrid PSO, K2 (we refer to it as QPSO-K2 algorithm), stand-alone K2 and quantum-behaved PSO algorithms are compared on several datasets. Among the three algorithms, the hybrid QPSO-K2 algorithm performs well for all of the datasets.
Keywords: Component, gene networks, quantum-behaved particle swarm optimization (QPSO), structure learning, K2 ALGORITHM, CONSTURCTION GENE NETWORK, acyclic graph, DNA microarray technology, root nodes, optimization algorithm
Current Bioinformatics
Title:Combining Quantum-Behaved PSO and K2 Algorithm for Enhancing Gene Network Construction
Volume: 8 Issue: 1
Author(s): Zhihua Du, Yingying Zhu and Weixiang Liu
Affiliation:
Keywords: Component, gene networks, quantum-behaved particle swarm optimization (QPSO), structure learning, K2 ALGORITHM, CONSTURCTION GENE NETWORK, acyclic graph, DNA microarray technology, root nodes, optimization algorithm
Abstract: Construction of the gene regulatory networks is a challenged problem in systems biology and bioinformatics. This paper presents construction of gene network using combined quantum-behaved PSO and K2 algorithm. Recent studies have shown that Bayesian Network is an effective way to learn the network structure. K2 algorithm is widely used because of its heuristic searching techniques and fast convergence, but it suffers from local optima. And the performance of K2 algorithm is greatly affected by a prior ordering of input nodes. Quantum-behaved PSO is a population-based stochastic search process, which automatically searches for the optimal solution in the search space. So, we combined it with K2 algorithm for construction gene network. The results of hybrid PSO, K2 (we refer to it as QPSO-K2 algorithm), stand-alone K2 and quantum-behaved PSO algorithms are compared on several datasets. Among the three algorithms, the hybrid QPSO-K2 algorithm performs well for all of the datasets.
Export Options
About this article
Cite this article as:
Du Zhihua, Zhu Yingying and Liu Weixiang, Combining Quantum-Behaved PSO and K2 Algorithm for Enhancing Gene Network Construction, Current Bioinformatics 2013; 8 (1) . https://dx.doi.org/10.2174/1574893611308010017
DOI https://dx.doi.org/10.2174/1574893611308010017 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Improved Candidate Biomarker Detection Based on Mass Spectrometry Data Using the Hilbert-Huang Transform
Protein & Peptide Letters Chemistry of Tumour Targeted T1 Based MRI Contrast Agents
Current Topics in Medicinal Chemistry Neuroprotective Effects of Quercetin: From Chemistry to Medicine
CNS & Neurological Disorders - Drug Targets Feature Selection Using Information Distance Measure for Gene Expression Data
Current Proteomics Identification of Disease-Relevant Genes for Molecularly-Targeted Drug Discovery
Current Cancer Drug Targets Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT
Current Cancer Drug Targets The Endocannabinoid System in the Cancer Therapy: An Overview
Current Medicinal Chemistry Emerging Role of Wnt/Beta-Catenin Signalling Pathways in Cancer Progression and Role of Small Molecule Tankyrase Inhibitors in Combating Multistage Cancers
Current Cancer Therapy Reviews Recent Patents on the Development of c-Met Kinase Inhibitors
Recent Patents on Anti-Cancer Drug Discovery Metabolomics for Personalized Nutrition Research and Clinical Applications
Current Pharmacogenomics and Personalized Medicine The Medicinal Chemistry Implications of the Anticancer Effects of Aspirin and Other NSAIDs
Mini-Reviews in Medicinal Chemistry Monoclonal Antibodies: A Prospective and Retrospective View
Current Medicinal Chemistry Role of Glioma-associated GLI1 Oncogene in Carcinogenesis and Cancertargeted Therapy
Current Cancer Drug Targets Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects
Current Pharmaceutical Design A Review on Melatonin’s Effects in Cancer: Potential Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Preface
Current Pharmaceutical Design In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations
Current Signal Transduction Therapy Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
Current Medicinal Chemistry Ovarian Toxicity: From Environmental Exposure to Chemotherapy
Current Pharmaceutical Design Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibitors
Current Medicinal Chemistry